Dihydrocodeine
Back to searchMolecule Structure
Scientific Name
Dihydrocodeine
Description of the Drug
Dihydrocodeine is an opioid analgesic agent used for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01551
http://www.drugbank.ca/drugs/DB01551
Brand Name(s)
Not Available
Company Owner(s)
Leitner Pharmaceuticals Llc, Pharmaceutical Research Assoc Inc, Wraser Pharmaceuticals Llc, Sun Pharmaceutical Industries Inc, Xspire Pharma, Mikart Llc, Larken Laboratories Inc, West-Ward Pharmaceutical Corp, Boca Pharmacal Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Mu opioid receptor | SINGLE PROTEIN | AGONIST | CHEMBL233 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL24607 | |
| DrugBank | DB01551 | |
| PubChem: Thomson Pharma | 14751770 | 14922962 |
| PubChem | 5284543 | |
| NMRShiftDB | 60067803 | |
| Nikkaji | J5.368F | |
| EPA CompTox Dashboard | DTXSID5022936 | |
| DrugCentral | 886 | |
| Metabolights | MTBLC135276 | |
| Guide to Pharmacology | 7594 | |
| rxnorm | DIHYDROCODEINE BITARTRATE | DIHYDROCODEINE |
| ChEBI | 135276 | |
| ZINC | ZINC000004215736 |
